Venaxis Inc. (APPY) News Nov 4, 2014, 4:45

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Venaxis Inc. (APPY) News Nov 4, 2014, 4:45 p.m.
MarketWatch News on APPY
'Dumb tourists', a dollar bull and one market chart analog too many 7:39 a.m. April 3, 2014 - Shawn Langlois
CACI slumps after outlook cut; Plug Power shares rise 4:56 p.m. April 2, 2014 - Wallace Witkowski
AspenBio: 4 directors leave; focus is on lead drug 8:06 a.m. Sept. 27, 2012 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 3:54 p.m. June 20, 2012 - MarketWatch

Other News on APPY
10-Q: VENAXIS, INC. 4:14 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Venaxis: Latest Clinical Data Reveals Huge Market Potential 10:48 a.m. Oct. 29, 2014 - Seeking Alpha
10-Q: VENAXIS, INC. 3:33 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Smith & Nephew (SNN) Crumbles: Stock Falls by 5.7% - Tale of the Tape 7:57 a.m. June 6, 2014 - Zacks.com
Cardica (CRDC) Jumps: Stock Rises 8.5% - Tale of the Tape 7:57 a.m. June 6, 2014 - Zacks.com
Haemonetics (HAE) Crumbles: Stock Falls 6.2% in Session - Tale of the Tape 7:31 a.m. April 29, 2014 - Zacks.com
Zimmer Holdings (ZMH) Soars: Stock Up 11.5% - Tale of the Tape 7:51 a.m. April 25, 2014 - Zacks.com
Agios Pharmaceuticals (AGIO) Crumbles: Stock Falls by 6.0% - Tale of the Tape 7:49 a.m. April 25, 2014 - Zacks.com
MacroGenics (MGNX) Jumps: Stock Up 7.5% - Tale of the Tape 8:39 a.m. April 24, 2014 - Zacks.com
GW Pharmaceuticals plc (GWPH) Soars: Stock Up 13.9% - Tale of the Tape 7:51 a.m. April 24, 2014 - Zacks.com
Weakness Seen in Unilife (UNIS): Stock Tumbles 10.9% - Tale of the Tape 7:49 a.m. April 23, 2014 - Zacks.com
2 Small Caps That Could Be On The Move Today 9:21 a.m. March 31, 2014 - Seeking Alpha
Venaxis up 27% premarket on positive study results 7:05 a.m. March 13, 2014 - Seeking Alpha
Venaxis expects APPY1 approval following positive trial; shares soar 6:41 a.m. March 13, 2014 - Seeking Alpha
What Every Investor Needs To Know About Venaxis, Inc. 3:51 p.m. Feb. 24, 2014 - Seeking Alpha
Venaxis: A Potentially Bright Future And An Interview With The CEO 9:36 a.m. Feb. 12, 2014 - Seeking Alpha
Venaxis's Pivotal Data Due In March 1:29 p.m. Feb. 6, 2014 - Seeking Alpha
Venaxis: Buy On The Rumor, Sell On The News.. Buy On The Sell-Off? 5:57 a.m. Feb. 6, 2014 - Seeking Alpha
Small Cap BioPharmas With Near Term Catalysts 7:55 a.m. Jan. 3, 2014 - Seeking Alpha
Imminent Catalysts Should Keep Investor Interest Strong For Venaxis In 2014 11:10 a.m. Dec. 30, 2013 - Seeking Alpha

Press Releases on APPY
Venaxis' APPY1 Trial Results Presented by Dr. David S. Huckins, M.D., at ACEP14 3:30 p.m. Oct. 27, 2014 - PR Newswire - PRF
Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14 3:05 p.m. Oct. 14, 2014 - PR Newswire - PRF
Venaxis to Provide Business Update, including FDA Submission Update 3:15 p.m. Aug. 7, 2014 - PR Newswire - PRF
Venaxis Reports on Recent FDA Submission Activities 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Venaxis to Present at ICV Company Outreach Summit 3:10 p.m. July 1, 2014 - PR Newswire - PRF
Venaxis to Participate in 11th Annual Craig-Hallum Institutional Investor Conference 3:15 p.m. May 21, 2014 - PR Newswire - PRF
Pre-Market Scans on Top Gainers -- Research on Athlon Energy, Venaxis, Desarrolladora Homex, and ImmunoGen 12:30 p.m. April 10, 2014 - PR Newswire - PRF
Venaxis, Inc. Closes Public Offering of Common Shares 3:01 p.m. April 8, 2014 - PR Newswire - PRF
Venaxis, Inc. Prices $20.0 Million Public Offering of Common Shares 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Venaxis, Inc. Announces Proposed Public Offering of Common Shares 3:01 p.m. April 2, 2014 - PR Newswire - PRF
Venaxis Files for FDA Clearance of APPY1 Test 6:30 a.m. March 31, 2014 - PR Newswire - PRF
Agreements, Financial Results, Clinical Study Results, Debt Financing, and Drug Application Updates - Analyst Notes on Tesaro, Chelsea Therapeutics, Venaxis, Geron, and Unilife 7:00 a.m. March 19, 2014 - PR Newswire - PRF
Venaxis Announces Positive Top-Line Results from Pivotal Study of APPY1 Test 6:00 a.m. March 13, 2014 - PR Newswire - PRF
Venaxis to Discuss Top-Line Results from Pivotal Study of APPY1 Test 4:15 p.m. March 12, 2014 - PR Newswire - PRF
Venaxis Completes Patient Enrollment in Pivotal Clinical Trial of APPY1™ Test 7:33 a.m. Jan. 24, 2014 - PR Newswire - PRF
Venaxis to Present at Biotech Showcase(TM) 2014 9:09 a.m. Jan. 9, 2014 - PR Newswire
Venaxis to Present at Piper Jaffray 25th Annual Healthcare Conference 4:05 p.m. Nov. 21, 2013 - PR Newswire
Venaxis to Present at Canaccord Genuity Medical Technology & Diagnostics Forum 4:05 p.m. Nov. 7, 2013 - PR Newswire
Venaxis Nears Completion of Pivotal Clinical Trial of APPY1(TM) Test 7:30 a.m. Nov. 7, 2013 - PR Newswire
Venaxis to Provide Third Quarter 2013 Business Update 3:10 p.m. Oct. 31, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SHOEBOX PureTest Wins 2026 Award for Audiometry Innovation

Updated Category News Views 4

Breaking New Ground in Hearing Conservation This time, we're looking at SHOEBOX PureTest snagging the 2026 Hearing Technology Innovator Award. It marks yet another feather in their cap, standing tall in the Equipment, Audiometry category. You know, for those of us knee-deep in the stock game—and I mean neck-deep in financial stakes—spotting a company thriving through...

Continue Reading
OTconnect on Apple Watch: A New Fitness Era Dawns

Updated Category News Views 6

What’s Orangetheory Up To Now? Ah, fitness gadgets, where everyone’s seemingly got a scheme brewing. This time it's Orangetheory (OTF), turning your Apple Watch into your new best gym buddy. October 22, 2026, marks the launch of OTconnect for Apple Watch, offering a slick way for enthusiasts to tune into their own sweat metrics. If you’re already an Apple Watch...

Continue Reading
AceMyNursingExams Debuts Versatile Nursing Prep Platform

Updated Category News Views 4

A Digital Lifeline for Nursing Students Nursing students are buried in responsibilities: lectures, clinical rotations, and sometimes even a job to fund the whole marathon. And just when they think they’ve got it handled, boom, a mountain of exams rises up in front of them. AceMyNursingExams gets this, rolling out an online exam prep platform to keep these future...

Continue Reading
MLS Org's Sue Compass to Safeguard Fair Listing Access

Updated Category News Views 5

Real Estate Clash: MLS vs. Compass Imagine flipping on the TV to see a legal showdown brewing in the real estate world — you've got six heavy-hitter MLSs facing off against Compass, Inc. Yeah, we're talking a legal slugfest here, folks, as these MLSs rally to keep the playing field level for over 120,000 agents across the country. They're not messing around, bringing a...

Continue Reading
Carrier Drops $600M on U.S. Manufacturing Boost

Updated Category News Views 7

A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...

Continue Reading
College Athletics Needs a New Business Revolution

Updated Category News Views 3

Wake Up Call for College Athletics Here's a heads-up—college sports aren't just about cheering fans and game-day jerseys anymore. It's high time universities start thinking of athletics as businesses, blending the thrill of game day with the realities of financial statements. Michael Schreiber rang this bell loud and clear on the 'Disruption Interruption' podcast,...

Continue Reading
Oak View Group Partners with Payactiv for Employee Benefits

Updated Category News Views 9

Bringing Financial Flexibility to Venue Employees Oak View Group (OVG) has taken a bold step toward enhancing the financial lives of its workforce. They’ve teamed up with Payactiv, the trailblazer in Earned Wage Access (EWA), to deliver a more flexible way for their employees to access funds they've already earned. This move stretches across more than 40 locations...

Continue Reading
ImmVira's Bladder Cancer Trials: Promising Data Revealed

Updated Category News Views 0

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Continue Reading
Lennox-Gastaut Syndrome: Unseen Struggles and Hope Ahead

Updated Category News Views 4

Asking the World to See LGS Life throws curveballs, but Lennox-Gastaut Syndrome (LGS) comes barreling down like a freight train in the quiet. It's a rare form of epilepsy that sows chaos in young lives with relentless seizures, leaving families in a fog of uncertainty and heartbreak for years. On International LGS Awareness Day™, November 1, families and advocates are...

Continue Reading
Ping An Good Doctor Grows 35%: AI's Expanding Role

Updated Category News Views 2

Ping An Good Doctor's Noteworthy Financial Uptick Stop me if you've heard this one: a hefty hike in numbers that make investors straighten up a bit. Ping An Good Doctor did just that, reporting a 35% spark in net profit as the books closed up till September 2026. In a landscape where many health-tech firms merely tread water, these guys rode a wave of RMB 0.25 billion in...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Alert: Edwards Lifesciences Faces Class Action Lawsuit

Updated Category News Views 238

Edwards Lifesciences and the Class Action Lawsuit Investors are being urged to take note of an important upcoming deadline concerning a class action lawsuit involving Edwards Lifesciences Corporation (NASDAQ: EW). With significant events unfolding within the company and its stock performance, it's crucial for investors to stay informed and consider their options...

Continue Reading
Charlotte's Web Plans 2024 Fourth Quarter Earnings Call

Updated Category News Views 235

Charlotte's Web Sets Stage for 2024 Fourth Quarter Earnings Call Charlotte's Web Holdings, Inc. is excited to announce its upcoming earnings call scheduled for March 19, 2025. This call will cover the company’s fourth-quarter and year-end results, presenting an overview of their successes and future strategies in the competitive cannabidiol (CBD) market. Details of the...

Continue Reading
Erma's at Fairmont: A Bold Move in Affordable Housing

Updated Category News Views 12

Affordable Housing Takes a Stand in Salt Lake City Picture this: a groundbreaking ceremony not just for a construction project, but a significant step toward addressing an acute affordability problem right in the heart of Salt Lake City. Lincoln Avenue Communities (LAC), along with the Housing Authority of Salt Lake City (HASLC), is rolling the dice on Erma's at...

Continue Reading
Holley Performance Brands Set for Q4 2024 Earnings Call

Updated Category News Views 122

Overview of Holley’s Upcoming Earnings Call Holley Performance Brands (NYSE: HLLY), a prominent name in automotive aftermarket performance solutions, has announced a significant event for its stakeholders. The company is gearing up to reveal its fourth quarter and full year financial results, marking an important moment for its investors and enthusiasts alike. Key...

Continue Reading
Important Notice for Humacyte, Inc. Shareholders on Class Action

Updated Category News Views 192

Key Information for Shareholders of Humacyte, Inc. The Gross Law Firm is reaching out to shareholders of Humacyte, Inc. (NASDAQ: HUMA) following significant developments in a lawsuit pertaining to the company. This notice aims to inform shareholders about crucial steps they can take regarding their investments and potential participation in this class action....

Continue Reading